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Summary: A working group of five läboratories cooperated in the Netherlands with the aim of proposing a useful and
well standardized method for the determination of total protein in cerebrospinal fluid. A survey model was used äs a
basis for the discussion of the praetical work. The biuret technique was chosen, representing a modification of the
selected method for serum.
Die Bestimmung von Protein im Liquor: Versuch einer Standardisierung
Zusammenfassung: Eine Arbeitsgruppe aus fünf Laboratorien in den Niederlanden arbeitete mit dem Ziel zusammen,
eine brauchbare und gut standardisierte Methode zur Bestimmung des Gesam1>Proteins im Liquor cerebrospinalis
vorzuschlagen. Als Basis für die Diskussion der praktischen Arbeit wurde ein Ringversuchsmodell benutzt. Das Biuret-
verfahren wurde gewählt; es ist eine Modifikation der für Serum angenommenen „Selected Method" zur Protein-
bestimmung in Liqiaorproben.
Introdüction accepted by a working group of five läboratories. These
0. . ·, *«r - i ·· j läboratories were chosen because oftheirexperienceSmce the pioneenng work öf Kafka the twenties and ^ ct and/Qr feecause rf their dafly WQrkload
thirties, on the significance of the determination of pro- (10^20 ks csp day) fa ̂  aftide only work
tein in cerebrospinal fluid many articles have been ^ ̂  determination of total proteins is reported. How-
written on this subject (1). Even now in our opinion, eye ^m iQ standardize the electrophoresis of CSF
Rice s Statement in 1965 is still true (2). ^ ̂  determinations of abutian ̂  rgiobulins are
"At present there is no highly accurate and precise proce- also being discussed in the Netherlands,
dure avaÜable for the determination pf total proteins As a compromise between all published methods,
in cerebrospinal fluid (CSF) ideally suitable for routine Kjeldahl, turbidimetric, nephelometric, biuret, dye-
use in a hospit^ clinical laboratory." binding, Lowy and so on, two approaches were chosen
Nevertheless, Ihe invitatipn of the Dutch Multipte i.e. the dye-binding technique with Coomassie Blue and
Sclerosis Foundation to give recotnmendations on the a modification of the biuret technique. The first because
Standardization of CSF protein examinations was of its simplicity and its sensitivity, äs well äs its growing
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populär!ty (3,4), the second because of its possible
connection with the selected method for serum analysis
(6, 7). In the biuret procedure it was decided to use
exactly the same reagents äs with the serum method;
owing to the low protein level in CSF, it was necessary
to add a concentration step.
Materials and Methods
Materials (p.a. quality)
1. Reagents biuret technique serum: see Doumas (6, 16).
2. Reagents biuret technique CSF; see reagents 1., 3., and 4.
3. Trichloroacetic acid (Merck), 100 g/l.
4. Phosphotungstic acid (Merck), 25 g in l mol/1 H2SO4 (H).
5. Sodium hydroxide (Merck), 100 g/l.
6. Human albumin, purified (Hoechst - Behringwerke AG).
7. Gamma globulins (Central Laboratory The Netherlands
Red Cross Blood Transfusion Service), 160 g/l.
Methods
1. Routine methods participating laboratories
a. Laboratory A: modified Lowry method described by
Rieder (8).
b. Laboratory L:\amido black absorption method described
by Schaffner et al. (9).
c. Laboratory N: automated, home-made, modification Lowry
technique.
d. Laboratory R: modified Lowry method described byPapa-
dopoulos (10).
e. Laboratory U: trichloroacetic acid turbidity technique (11).
2. Methods also used in the surveys
a. ßradford technique (3).
b. Rieder technique (8).
c. Pierce technique: Pierce Rapid Stat® Kit Microprotein,
productno. 45700.
d. Biuret technique, see below
3. Recommended method spinal fluid
a. Sample
To 1.0 ml of spinal fluid 1.0 ml of deproteinizing agent
(trichloroacetic acid or phosphotungstic acid) is added.
After mixing and Standing for 10 minutes the sample is
centrifuged at 3000 min"1 for 10 minutes. After decanting
the supernatant the precipitate is blotted carefully with
fdter paper and dissolved in 0.1 ml of NaOH (100 g/l). Then
2.0 ml of biuret reagent is added, after mixing and incuba-
tion for 30 minutes, the absorbance of the sample is read
in a spectrophotometer at 540 nm against the reagent blank.
b. Reagent blank
Saline is used instead of spinal fluid.
c. Sample blank
In case of xanthochromia a sample blank has to be measured
according to Doumas.
In normal colourless samples this blank can be neglected.
4. Total protein determination in serum: see Doumas et al. (6, 16).
Results
As mentioned in the Introduction a Coomassie Blue
and a biuret procedure were chosen. However, the pro-
ject was not started that way. After lengthy discussions
on the advantages and the disadvantages of the värious
methods it was decided to organize the study with the
help of surveys. A first survey was organized to become
acquainted with the model of study and to give a prac-
tical basis for discussion.
The following methods were included:
a) the routine method of the participating laboratory;
b) the Coomassie Blue method according to Bradford;
c) the Coomassie Blue method by means of a comrriercial
kit (Pierce);
d) a pfocedure based on the Lowry technique äs described
by Rieder
e) a biuret technique adäpted to spinal fluid.
All laboratories were asked to gain experience with two
or three methods not or partially known before the
survey started. Without riientioning the resülts it cari be
said that the general opinion afterwards was negative
with the respect to the ßradford and the Rieder
technique. The Bradford method showed pppr colour
stability, and the Rieder prpcedure (in pur opinion the
method with the most "selected method capacities")
was feit to be somewhat cumbersome, äs well äs givirig
different colöur yields for the värious protein fractions (5).
The results obtained with the Pierce kit and the biuret
technique looked promising. Therefore, it was decided
to concentrate more on pur biuret modification in ä
second survey. In this survey we combined the analysis
of serum samples with the seleeted biuret method with
the analysis of 100 and 200-fold salina dilutions pf
these sera with the "micro" biuret technique. In addi-
tion, severäl spinal fluid samples were analyzed.
All specimens (included Standards) cäme from one
central point. As a second compärfson we all used the
Pierce kit for the serum dilutions. This survey was cori-
clusive. Our choiee was made for the biuret procedure.
In the third and final survey, therefore, we used all the
experience obtained with the forgoing surveys. In this.
experiment the routine methods of all participating
laboratories i.e. the state of the art, were cPmpared with
the biiiret technique äs well äs the Coomassie Blue pro-
cedure. We analysed six spinal fluid samples, five diluted
serum samples and six diluted commercial sera. The
results are shown in table l.
Furthermore the comparability between the serum and
CSF biuret methods äs well äs the transferability of the
CSF procedure were tested by analysing 10—20 sera,
diluted and ündiluted. This was done by all participating
laboratories separately. In figure l the results Pf the
serum analyses are given on the x-axis (recalculated on
the basis of the saline dilution). The y-axis shows the
measured values. ,
The overall Impression of fhe CSF biuret technique, äs
can be seen in figure l and table l was encouräging, so
we continued by studying severäl aspects of the method
i.e. calibration, precision, matrix effeqts and proteiuri con-
centration. »
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Calibration
The preparation of the Standard in the serum determi-
nation has been published in detail (6, 7). We followed
the same procedure with one extra step, i.e. dilution
with saline. Because of the special role γ-globulins may
play in the CSF of multiple sclerosis patients, attention
'was paid to aJbumin-globulin based Standards. In
figure 2 the results of some mixtures are given.
Because it is easier to handle and because of the small
differences between albumin Standards and the albumin-
globulin mixtures (fig. 2) we chose a Standard based on
human albumin only. In an attempt to confirm the
correctness of this decision a number of serum speci-
mens with elevated γ-globulin fractions was analysed.
This was done in the same way s mentioned earlier
(fig. i)·
The results proved to be highly comparable with the
results given in figure 1 .
The linearity of the calibration graph was not studied
in detail. However, a straight line was found up to
2000 mg/1.

















Results of survey 3. For a description of all the methods
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Fig. 1. Comparison of calculated vs. measured protein values.
Calculated: measurement of seium samples (see Methods)
and dil tions with saline.
Measured: measurement of dil tions (see Methods) after
precipitation with trichloroacetic acid y (measured) =
0.99 χ (calculated) - 9.
n-142 r = 0.99 x = 485mg/l y = 470 mg/1
Precision
The within-run precision for the CSF biuret technique
was determined at tfcree different levels i.e. a high, low
and middle value, while the day-to-day precision was
estimated at one level (rniddle value). The data are shown
in table 2.
Matrix effects
To determiiie whether the foregoing results, in most
cases obtained with saline diluted serum and diluted
Duplicate measufements from one laboratory. Value S
known by applying serum biuret procedure, value A
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human albumin samples, were compatible witli spinal
fluid specimens, five different CSF sainples were diluted
(l :2) witli an arbitrarily chosen serum sample and a
Standard.
The data are given in table 3.
As a second approach to the study of the matrix effects
of diluted serum in comparison with spinal fluid, three
different serum specimens were diluted and analyzed.
The slopes of these lines are shown in figure 3.
Protein concentration
Trichloroacetic acid äs deproteinizing agent is well
known in clinical chemistry. Therefore it was also chosen
in this study. We checked the effect of two different con-
centrations (100 and 200 g/l) äs well äs the effect of
boiling of the mixture. We could detect no differences.
However, in the dilution graphs mentioned above
(figs. l and 2) the results measured were generally
slightly lower than the results "calculated". In addition,
the absorbance values of the Standards seem somewhat
lower than the values calculated on the basis of the
serum procedure (see under Discussion). Some of us
even found an intersection of the x-axis.
We decided to follow the Suggestion ofBürgi et al. who
used phosphotungstic acid äs a protein precipitant (12).
Because of the "higher" calibration graph obtained with
phosphotungstic acid we found it worthwhile to repeat
the experiment described in figure l. The results are
shown in figure 4:
Furthermore the trichloroacetic acid and the phospho-
tungstic acid modification were compared. These results
are given in figure 5.
Discussion
In an attempt to recommend a spinal fluid protein deter-
mination which could meet certain standardization
criteria we studied various possibilities.
As a basis of this study the survey model was chosen
because of the distance between the cooperating labor-
atories (up to 150 km). With the help of this model
several determinations äs well äs several aspects of
these determinations were studied.
As a result of all discussions and practical work two
methods were chosen i.e. a dye-binding technique with
Coomassie Blue and a modification of the biuret
technique. We did not study the Coomassie Blue
procedure (3,4) in great detail, with the exception of
one of us (E. A. H.); it was only chosen because of its
easiness of Operation especially with the commercial
kit. A drawback of the method is the different weight
of the various proteins in the colour reaction (13).
Moreover, recommendation of "our" Coomassie Blue
procedure would have been blöcked, äs the reagents are
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Fig. 2. Calibration graphs with albumin and albumin-y-giobuiin
mixtüres. Saline dilutions from albumin (50 g/l) and
7-globulin (47 g/l).
l s. albuniin 2 ̂  albumin-globulin (4 + 1) 3 = aibumin-
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Fig. 3. Saline dilutions of three different patient sera.
Therefore, we concentrated on a determination based
on the well known biuret reaction i.e. the procedure
recornrhended by the National Clinical Chemistry
Laboratory Standardization (NCCLS) Committee and
also by the Dutch Standardization Cömmittee for
Clinical Chemistry. This procedure is only described
for serum or plasma. Thus, a "translation" to spinal
fluid was needed. This was done by introducing
a protein concentratipn Step. The suitability of our
CSF biuret modification is shown by figure l and
table l. In fact, figure l is a combination of the
transferability of the serum procedure to a spinal
fluid procedure äs well äs ä proof of the high preci-
sion which can be obtained in both cäses. In this case,
all pafticipants were left free with respect to the
reaigent preparatiori and the choice of the samples. It
is even remarkable that the precisiorvis better than the
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Fig. 4. Comparison of calculated vs. measured protein values.
Calculated: measurement of serum samples (see Methods)
and dilutions with saline.
Measured: measurement of dilutions (see Methods) after
precipitation with phosphotungstic acid.
y (measured) = 0.98 χ (calculated) + 4 n = 116 r = 0.99
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Protein (trichloroacetic acid precipitation)[mg/l]
Fig. 5. Comparison of measurements of diluted serum samples
x-axis: trichloroacetic acid precipitation
y-axis: phosphotungstic acid precipitation
y = 0.99x + 16 n = 62 r = 0.98 χ = 468 mg/1
y = 482 mg/1
precision we obtained with a simple technique like
the Coomassie Blue technique (see tab. 1). Table l is
rather embarassing when the ac ial Situation is con-
sidered. It shows the need for improvement very con-
vincingly.
An answer to the question of accuracy and precision
of a CSF protein determination is very difficult. How-
ever, a comparison betweeii the state of the art, now
and possibly in the future, strongly favours the biuret
technique, or at le st a standardization against this
technique.
From figure 3 and table 3 it is clear that diluted serum
was a good substitute for spinal fluid in our experi-
ments.
The experiments described under Res lts (protein con-
centration) will possibly give a tool for a descnption
of the calibrating solution s well s a proof f the cor-
rectness pf the protein concentration step to be chosen.
In. the selected method for total proteins in serum used
in The Netherlands an abs rbance pf 0.287-0.293 is
accepted for the Standard human albumin solution of
50 g/l (sample volume 0.1 ml, end volume 5.1 ml) (see
sisoDoumas (16)). Assuming a volume of 0.1 ml for the
proteins precipitated in the CSF procedtire described
under Materials and Methods one can calculate that
this means for a CSF-albun n Standard of 500 mg/1
0.066-0.070 absorbance units. This figure, which was
found in practice, favours the deproteinization with
phosphotungstic acid (see fig. 2). The correctness of this
Statement is further demoiistrated by figures 4 and 5.
With the data shown in the tables and in the figures,
one can enquire s to the practical Utility of this study.
In our opinion two approaches can be chosen i.e.
1) to use the method described in daily routine or
2) to use it s a selected method for the determination
of total proteins in cerebrospinal fluid.
With respect to the first possibility, it is feit that the
absorbance of the biuret colour in the CSF is rather low
i.e. 0.030—0.080 absorbance units in the reference r nge.
Furthermpre, the sample volume we used is rather high
' (l Ό ml). Although we feel that these disadvantages can
be minimized by using a high quality spectrophotometer
and by taking lower sample vplumes, we are of the
opinion that the second approach is more useful. In
this approach the sample volume is less important. More-
pver, it is self-evident that a high performance spectro-
photometer must be used. And of course, the application
of a selected method does necessitate special care at
every stage.
Therefore, with respect to the second approach the close
agreement in methodology in serum and spinal fluid
assays is, in our opinion, a very striking feature. There-
fore, in spite of a othef recommended methods (e.g.
I.e. (14) and I.e. (15)), we propose this study s a basis
for the description of the selected method for the deter-
mination of CSF total proteins.
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